These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31981110)

  • 1. Increased Prevalence of Obesity and Metabolic Syndrome in Patients with Alcoholic Fatty Liver Disease.
    Singh A; Amin H; Garg R; Gupta M; Lopez R; Alkhouri N; MCCullough A
    Dig Dis Sci; 2020 Nov; 65(11):3341-3349. PubMed ID: 31981110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.
    van den Berg EH; Amini M; Schreuder TC; Dullaart RP; Faber KN; Alizadeh BZ; Blokzijl H
    PLoS One; 2017; 12(2):e0171502. PubMed ID: 28152105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease.
    Younossi ZM; Stepanova M; Ong J; Yilmaz Y; Duseja A; Eguchi Y; El Kassas M; Castellanos-Fernandez M; George J; Jacobson IM; Bugianesi E; Wong VW; Arrese M; de Ledinghen V; Romero-Gomez M; Mendez-Sanchez N; Ahmed A; Wong R; Papatheodoridis G; Serfaty L; Younossi I; Nader F; Ziayee M; Afendy A;
    Clin Gastroenterol Hepatol; 2019 Jul; 17(8):1625-1633.e1. PubMed ID: 30476585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
    Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
    Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of non-alcoholic fatty liver disease and metabolic syndrome in a Chinese population.
    Lee SW; Lee TY; Yang SS; Peng YC; Yeh HZ; Chang CS
    Hepatobiliary Pancreat Dis Int; 2017 Apr; 16(2):176-180. PubMed ID: 28381382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and metabolic abnormalities as risks of alcoholic fatty liver in men: NAGALA study.
    Yoshimura Y; Hamaguchi M; Hashimoto Y; Okamura T; Nakanishi N; Obora A; Kojima T; Fukui M
    BMC Gastroenterol; 2021 Aug; 21(1):321. PubMed ID: 34372774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
    Yi M; Chen RP; Yang R; Chen H
    Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of non-alcoholic fatty liver disease and metabolic risk factors in Guatemala: A population-based study.
    Rivera-Andrade A; Kroker-Lobos MF; Lazo M; Freedman ND; Smith JW; Torres O; McGlynn KA; Groopman JD; Guallar E; Ramirez-Zea M
    Nutr Metab Cardiovasc Dis; 2019 Feb; 29(2):191-200. PubMed ID: 30573307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population.
    Jinjuvadia R; Antaki F; Lohia P; Liangpunsakul S
    J Clin Gastroenterol; 2017 Feb; 51(2):160-166. PubMed ID: 27580477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China.
    Fan JG
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():11-7. PubMed ID: 23855290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum testosterone and non-alcoholic fatty liver disease in men and women in the US.
    Yim JY; Kim J; Kim D; Ahmed A
    Liver Int; 2018 Nov; 38(11):2051-2059. PubMed ID: 29517842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Psoriasis With Comorbidity Development in Children With Psoriasis.
    Tollefson MM; Van Houten HK; Asante D; Yao X; Maradit Kremers H
    JAMA Dermatol; 2018 Mar; 154(3):286-292. PubMed ID: 29322175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for liver disease among adults of Mexican descent in the United States and Mexico.
    Flores YN; Zhang ZF; Bastani R; Leng M; Crespi CM; Ramírez-Palacios P; Stevens H; Salmerón J
    World J Gastroenterol; 2018 Oct; 24(37):4281-4290. PubMed ID: 30310261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the prevalence of metabolic syndrome and its components in the United States 2007-2014.
    Shin D; Kongpakpaisarn K; Bohra C
    Int J Cardiol; 2018 May; 259():216-219. PubMed ID: 29472026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Lipids, Obesity, Metabolic Syndrome, and Diabetes Mellitus in the United States: An NHANES Analysis (2003-2004 to 2013-2014).
    Palmer MK; Toth PP
    Obesity (Silver Spring); 2019 Feb; 27(2):309-314. PubMed ID: 30677260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for pure steatosis in alcoholic patients.
    Naveau S; Thaury J; Barri-Ova N; Balian A; Dauvois B; Njiké-Nakseu M; Prévot S; Agostini H; Perlemuter G
    Alcohol Clin Exp Res; 2009 Jun; 33(6):1104-10. PubMed ID: 19382900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soft drinks consumption is associated with nonalcoholic fatty liver disease independent of metabolic syndrome in Chinese population.
    Meng G; Zhang B; Yu F; Li C; Zhang Q; Liu L; Wu H; Xia Y; Bao X; Shi H; Su Q; Gu Y; Fang L; Yang H; Yu B; Sun S; Wang X; Zhou M; Jia Q; Jiao H; Wang B; Guo Q; Carvalhoa LA; Sun Z; Song K; Yu M; Niu K
    Eur J Nutr; 2018 Sep; 57(6):2113-2121. PubMed ID: 28702720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence and clinical features of non-alcoholic steatohepatitis in a hypertensive population].
    García-Carretero R; Barquero-Pérez O; Mora-Jiménez I; Soguero-Ruiz C; Goya-Esteban R; Rodríguez-Castro C; Ramos-López J
    Hipertens Riesgo Vasc; 2019; 36(3):130-136. PubMed ID: 30655210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and determinants of metabolic syndrome in Qatar: results from a National Health Survey.
    Al-Thani MH; Al-Thani AA; Cheema S; Sheikh J; Mamtani R; Lowenfels AB; Al-Chetachi WF; Almalki BA; Hassan Khalifa SA; Haj Bakri AO; Maisonneuve P
    BMJ Open; 2016 Sep; 6(9):e009514. PubMed ID: 27601485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.